146 related articles for article (PubMed ID: 32725507)
21. MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors.
Patel D; Boufraqech M; Jain M; Zhang L; He M; Gesuwan K; Gulati N; Nilubol N; Fojo T; Kebebew E
Surgery; 2013 Dec; 154(6):1224-8; discussion 1229. PubMed ID: 24238045
[TBL] [Abstract][Full Text] [Related]
22. Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome.
Ronchi CL; Sbiera S; Altieri B; Steinhauer S; Wild V; Bekteshi M; Kroiss M; Fassnacht M; Allolio B
Endocr Relat Cancer; 2015 Aug; 22(4):531-43. PubMed ID: 25979380
[TBL] [Abstract][Full Text] [Related]
23. Adrenal cortical neoplasms: a study of clinicopathological features related to epidermal growth factor receptor gene status.
Zhang J; Wang C; Gao J; Sun J; Zeng X; Wu S; Liang Z
Diagn Pathol; 2014 Jan; 9():19. PubMed ID: 24457059
[TBL] [Abstract][Full Text] [Related]
24. Parathyroid Neoplasms: Immunohistochemical Characterization and Long Noncoding RNA (lncRNA) Expression.
Yu Q; Hardin H; Chu YH; Rehrauer W; Lloyd RV
Endocr Pathol; 2019 Jun; 30(2):96-105. PubMed ID: 31119524
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining.
Gan W; Han X; Gong Y; Yang Y; Wang C; Zhang Z
Diagn Pathol; 2024 May; 19(1):71. PubMed ID: 38802933
[TBL] [Abstract][Full Text] [Related]
26. A Diagnostic Approach to Adrenocortical Tumors.
Hodgson A; Pakbaz S; Mete O
Surg Pathol Clin; 2019 Dec; 12(4):967-995. PubMed ID: 31672302
[TBL] [Abstract][Full Text] [Related]
27. The construction and analysis of tumor-infiltrating immune cells and ceRNA networks in metastatic adrenal cortical carcinoma.
Huang R; Liu Z; Tian T; Song D; Yan P; Yin H; Hu P; Zhu X; Liu Y; Li Z; Meng T; Zhang J; Huang Z
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32175564
[TBL] [Abstract][Full Text] [Related]
28. Dysregulation of microRNAs in adrenocortical tumors.
Singh P; Soon PS; Feige JJ; Chabre O; Zhao JT; Cherradi N; Lalli E; Sidhu SB
Mol Cell Endocrinol; 2012 Mar; 351(1):118-28. PubMed ID: 21996374
[TBL] [Abstract][Full Text] [Related]
29. Nestin as a marker in the classification of adrenocortical tumors.
Lachenmayer A; Lichtenauer UD; Cox T; Schott M; Malendowicz LK; Goretzki PE; Cupisti K; Scherbaum WA; Bornstein SR; Willenberg HS
Horm Metab Res; 2009 May; 41(5):397-401. PubMed ID: 19294612
[TBL] [Abstract][Full Text] [Related]
30. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
[TBL] [Abstract][Full Text] [Related]
31. IGF2 role in adrenocortical carcinoma biology.
Pereira SS; Monteiro MP; Costa MM; Moreira Â; Alves MG; Oliveira PF; Jarak I; Pignatelli D
Endocrine; 2019 Nov; 66(2):326-337. PubMed ID: 31378849
[TBL] [Abstract][Full Text] [Related]
32. Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.
Wang Y; Hardin H; Chu YH; Esbona K; Zhang R; Lloyd RV
Endocr Pathol; 2019 Dec; 30(4):262-269. PubMed ID: 31468286
[TBL] [Abstract][Full Text] [Related]
33. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
[TBL] [Abstract][Full Text] [Related]
34. Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors.
Barzon L; Chilosi M; Fallo F; Martignoni G; Montagna L; Palù G; Boscaro M
Eur J Endocrinol; 2001 Aug; 145(2):207-12. PubMed ID: 11454518
[TBL] [Abstract][Full Text] [Related]
35. The molecular basis of adrenocortical cancer.
Lehmann T; Wrzesinski T
Cancer Genet; 2012 Apr; 205(4):131-7. PubMed ID: 22559973
[TBL] [Abstract][Full Text] [Related]
36. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
[TBL] [Abstract][Full Text] [Related]
37. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors.
Barzon L; Pacenti M; Masi G; Stefani AL; Fincati K; Palù G
Oncology; 2005; 68(4-6):414-21. PubMed ID: 16020971
[TBL] [Abstract][Full Text] [Related]
38. Contribution of the microvessel network to the clonal and kinetic profiles of adrenal cortical proliferative lesions.
Diaz-Cano SJ; de Miguel M; Blanes A; Galera H; Wolfe HJ
Hum Pathol; 2001 Nov; 32(11):1232-9. PubMed ID: 11727263
[TBL] [Abstract][Full Text] [Related]
39. A diagnostic approach to adrenal cortical lesions.
McNicol AM
Endocr Pathol; 2008; 19(4):241-51. PubMed ID: 19089656
[TBL] [Abstract][Full Text] [Related]
40. Is there a role for epithelial-mesenchymal transition in adrenocortical tumors?
Bulzico D; Faria PAS; Maia CB; de Paula MP; Torres DC; Ferreira GM; Pires BRB; Hassan R; Abdelhay E; Vaisman M; Vieira Neto L
Endocrine; 2017 Nov; 58(2):276-288. PubMed ID: 28887601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]